Healthcare -
Biotechnology - NASDAQ - US
$ 1.61
-3.01 %
$ 60.2 M
Market Cap
-1.38
P/E
PDSB - COST OF REVENUE
Cost of Revenue PDSB - PDS Biotechnology Corporation
57.3 K
LAST VALUE
-51.76%
2 YEAR CAGR
-3.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR